Overview A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus Status: Completed Trial end date: 2016-10-31 Target enrollment: Participant gender: Summary This study is being to see how effective and safe ALS-008176 is in treating adults in the hospital with a Respiratory Syncytial Virus-Related Illness. Phase: Phase 2 Details Lead Sponsor: Alios Biopharma Inc.